SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-148212
Filing Date
2023-05-18
Accepted
2023-05-18 16:33:06
Documents
17
Period of Report
2023-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d408961d8k.htm   iXBRL 8-K 33939
2 EX-1.1 d408961dex11.htm EX-1.1 252163
3 EX-5.1 d408961dex51.htm EX-5.1 7525
4 EX-99.1 d408961dex991.htm EX-99.1 9777
8 GRAPHIC g408961g0518104639756.jpg GRAPHIC 2599
9 GRAPHIC g408961g0518194704673.jpg GRAPHIC 2668
  Complete submission text file 0001193125-23-148212.txt   510118

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA caba-20230517.xsd EX-101.SCH 2866
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20230517_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20230517_pre.xml EX-101.PRE 11718
11 EXTRACTED XBRL INSTANCE DOCUMENT d408961d8k_htm.xml XML 3468
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 23936591
SIC: 2836 Biological Products, (No Diagnostic Substances)